Discover the latest up-to-date treatments for managing MS in BeeWellWithMS. Learn about the role of the immune system in MS and various drugs used to slow down disease progression, including Ocrelizumab, Cladribine, Teriflunomide, Interferon-beta, Glatiramer acetate, and Bruton Tyrosine Kinase Inhibitors (BTKi) and many other DMTs. We explore the question, "Is MS Curable These Days?" and the limitations of current B-cell therapies in curing MS.In this episode of BeeWellWithMS, we explore the innovative ways of managing MS with the latest up-to-date treatments. We discuss the role of the immune system in MS and how it goes wrong, leading to MS symptoms. We use analogies to explain how T and B cells interact and the role of the drugs in the body. We discuss various drugs used to manage MS, including Ocrelizumab, Ofatumumab, Cladribine, Teriflunomide, Interferon-beta, Glatiramer acetate, interferon-beta, fingolimod, dimethyl fumarate(Tecfidera), and the promising new class of drugs, Bruton Tyrosine Kinase Inhibitors (BTKi), Alemtuzumab, AHSCT. We also delve into the question, "Is MS Curable These Days?" and the limitations of the current B-cell therapies in curing MS. We explain that while current therapies do not cure MS, they can slow down disease progression and reduce new symptoms, leading to a better quality of life for MS patients. We also discuss the ongoing research on the impact of BTKi on MS and its potential for being a game-changer in MS treatment.Tune in to BeeWellWithMS to learn more about the innovative ways of managing MS with the latest up-to-date treatments.Become a supporter of this podcast: https://www.spreaker.com/podcast/beewellwithms-podcast-by-dr-agne-straukiene--5762905/support.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related